DE2759297B1 - Process for the preparation of 2-oxo-1-pyrrolidine-acetamide - Google Patents
Process for the preparation of 2-oxo-1-pyrrolidine-acetamideInfo
- Publication number
- DE2759297B1 DE2759297B1 DE2759297A DE2759297A DE2759297B1 DE 2759297 B1 DE2759297 B1 DE 2759297B1 DE 2759297 A DE2759297 A DE 2759297A DE 2759297 A DE2759297 A DE 2759297A DE 2759297 B1 DE2759297 B1 DE 2759297B1
- Authority
- DE
- Germany
- Prior art keywords
- oxo
- pyrrolidine
- acetamide
- amide
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims description 6
- 238000002360 preparation method Methods 0.000 title claims description 3
- GMZVRMREEHBGGF-UHFFFAOYSA-N Piracetam Chemical compound NC(=O)CN1CCCC1=O GMZVRMREEHBGGF-UHFFFAOYSA-N 0.000 title description 6
- 229920001467 poly(styrenesulfonates) Polymers 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- 150000001408 amides Chemical class 0.000 claims description 3
- 150000002500 ions Chemical class 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- ILFDIIJNFWWVNM-UHFFFAOYSA-N n-(2-amino-2-oxoethyl)-4-chlorobutanamide Chemical compound NC(=O)CNC(=O)CCCCl ILFDIIJNFWWVNM-UHFFFAOYSA-N 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- BEBCJVAWIBVWNZ-UHFFFAOYSA-N glycinamide Chemical compound NCC(N)=O BEBCJVAWIBVWNZ-UHFFFAOYSA-N 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000007363 ring formation reaction Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 238000005349 anion exchange Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- JGPIWNNFLKDTSR-UHFFFAOYSA-N 2-(2-oxopyrrolidin-1-yl)acetic acid Chemical compound OC(=O)CN1CCCC1=O JGPIWNNFLKDTSR-UHFFFAOYSA-N 0.000 description 1
- IPLKGJHGWCVSOG-UHFFFAOYSA-N 4-chlorobutanoic acid Chemical compound OC(=O)CCCCl IPLKGJHGWCVSOG-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 1
- VXIVSQZSERGHQP-UHFFFAOYSA-N chloroacetamide Chemical compound NC(=O)CCl VXIVSQZSERGHQP-UHFFFAOYSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- PXSFGMATQMURKO-UHFFFAOYSA-N dichloromethane;methanol;propan-2-one Chemical compound OC.ClCCl.CC(C)=O PXSFGMATQMURKO-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Description
Es ist bekannt, daß das 2-Oxo-i-pyrrolidin-acetamid durch Reaktion von 2-Oxo-pyrrolidin-Na (hergestelk aus 2-Oxo-pyrrolidin und Na oder NaOtI) mit 2-ChIoracetamid, ferner durch Einwirken von NH3 adf 2-Oxo-l-pyrrolidin-essigsäureester oder -chlorid (GB 10 39 113) oder durch thermische Zersetzung Sires Ammoniumsalzes (GB 13 09 692) hergestellt werden kann. Die erwähnte Verbindung zeigt beispielsweise therapeutische Wirkung bei der Behandlung chronischer Störungen der Gehirnfunktion. Sie ist bekannt unter dem ,genetische» Namen Pyracetam.It is known that 2-oxo-i-pyrrolidine-acetamide is produced by reaction of 2-oxo-pyrrolidine-Na (produced from 2-oxo-pyrrolidine and Na or NaOtI) with 2-chloroacetamide, and also by the action of NH 3 adf 2-Oxo-1-pyrrolidine-acetic acid ester or chloride (GB 10 39 113) or by thermal decomposition of Sires ammonium salt (GB 13 09 692) can be prepared. The compound mentioned shows, for example, a therapeutic effect in the treatment of chronic disorders of the brain function. It is known by the "genetic" name pyracetam.
Es wurde nun gefunden, daß die Verbindung der Formel 1 auf einfache Weise entsprechend dem folgenden Reaktionsschema hergestellt werden kann:It has now been found that the compound of formula 1 in a simple manner according to the the following reaction scheme can be produced:
2H2N-CH2-CONH2 + (H)2H 2 N-CH 2 -CONH 2 + (H)
(IH)(IH)
ClCH2 -CH2 -Ch2-CONH-CH2-CONH2 (IV)ClCH 2 -CH 2 -Ch 2 -CONH-CH 2 -CONH 2 (IV)
(V) i (V) i
CH2CONH2
(HCH 2 CONH 2
(H
Erfindungsgemäß wird Glycinamid in Ν,Ν-Dknethylacetamid gelöst und stufenweise der abgekühlten Lösung des Chlorids der 4-Chlorbuttersiure in einem aprotischen organischen Lösungsmittel zugesetzt Der entstandene Niederschlag des Gh/cinamidsatzes der Formel V wird zur Regenerierung des Glydnamids nitriert, während das leicht flüchtige Lösungsmittel aus dem Filtrat unter vermindertem Druck entfernt wird. Das Produkt wird unter Zusatz eines geeigneten Lösungsmittels, in welchem das Produkt unlösfich ist, aus dem Ruckstand ausgefällt Das erhaltene 4-Chkwbutyrylglycinatnid wird anschließend in Alkohol gelöst und in Gegenwart von Natriumhydroxid oder eines Natriumalkoholtes, oder des basischen Anionenaustau· schers Dowex 1 in 2-Oxo-l-pyrrondin-acetamid umgewandelt, welches aus der Reaktionslosung nach Entfernen des Lösungsmittels isoliert wird.According to the invention, glycine amide is converted into Ν, Ν-Dknethylacetamid dissolved and gradually cooled down Solution of the chloride of 4-chlorobutyric acid in one aprotic organic solvent added. The resulting precipitate of Gh / cinamidatzes of Formula V is used to regenerate Glydnamide nitrated while the volatile solvent is off the filtrate is removed under reduced pressure. The product is made with the addition of a suitable Solvent in which the product is insoluble, precipitated from the residue. The 4-Chkwbutyrylglycinatnid obtained is then dissolved in alcohol and in the presence of sodium hydroxide or one Sodium alcohol, or basic anion exchange Scher's Dowex 1 converted into 2-oxo-l-pyrrondine acetamide, which from the reaction solution after Removing the solvent is isolated.
Der Vorteil des erfindungsgemifien Verfahrens besteht darin, daß die Anwendung von Natrium bzw. Natriumhydrid und das Verfahren mit dem intermediären Ammoniumsalz vermieden wird, so daß das erfindungsgemäße Verfahren einfach durchzuführen ist Ferner sind die Ausgangsstoffe leicht zugänglich.The advantage of the method according to the invention is that the use of sodium or Sodium hydride and the process with the intermediate ammonium salt is avoided, so that the The process according to the invention is easy to carry out. Furthermore, the starting materials are easily accessible.
Herstellung der Ausgangsverbindung
4-Chtorbutyrylglycinamid der Formel IVPreparation of the starting compound
4-chlorobutyrylglycine amide of the formula IV
11,1g (0,15MoI) Glycinamid werden in 5OnU Ν,Ν-Dimethylacetamid unter leichtem Erwärmen gelöst und zu der Lösung stufenweise 10,55 g (0,075MoI) Chlorid der 4-Chk>rbuttersäure in 50 ml wasserfreiem Dioxaa tmter Bskahking zugesetzt Danach wird die Reaktionslösung noch weitere 10 Minuten bei Zimmertemperatur geröhrt end der entstandene Niederschlag filtriert Man erhält 8 g Glycinamid HCL. Das Lösungsmittel Dkwcan wird durch Destillation im Vakuum entfernt und das Produkt mit Äther aus dem Rucksund abgeschieden. Man erhält 103 g (78%) des Produktes, Fj t23 - \ 25°C11.1g (0.15MoI) glycine amide are dissolved in 5OnU Ν, Ν-dimethylacetamide with gentle warming and then 10.55 g (0.075MoI) chloride of 4-chk> rbutyric acid in 50 ml anhydrous dioxa tmter Bskahking are gradually added to the solution the reaction solution is stirred for a further 10 minutes at room temperature and the precipitate formed is filtered off. 8 g of glycinamide HCl are obtained. The Dkwcan solvent is removed by distillation in vacuo and the product is separated from the backwater using ether. This gives 103 g (78%) of product, Fj t23 - \ 25 ° C
Das Produkt zeigt im DOnnschichtchromatognunm auf SBicagel mk Methytenchlorid-Aceton-Methanol = 5:5:1 nur einen Fleck bei Rf 0,43 (Nachweis durch Besprühen mit Iod).The product shows in thin-layer chromatography on SBicagel mk methylene chloride-acetone-methanol = 5: 5: 1 only one spot at Rf 0.43 (detection by spraying with iodine).
Zu Analysenzwecken wird das Produkt aus einer Mischung von Aceton mit Hexan oder Äthylacetat umkristaffisiert, wobei farblose Plättchen erhalten werden,Fpl28-130°CFor analytical purposes, the product is made from a mixture of acetone with hexane or ethyl acetate recrystallized, giving colorless platelets be, mp 28-130 ° C
Berechnet: C 4034, H 421. N 15,68%;
gefunden: C 40,46, H 5,97, N 15,54%.Calculated: C 4034, H 421. N 15.68%;
Found: C 40.46, H 5.97, N 15.54%.
340Θ, 3310,3200(NH2, NH),340Θ, 3310, 3200 (NH 2 , NH),
1680- 1620(C -0, prim. + sek. Amid).1680-1620 (C-0, prim. + Sec. Amide).
1550-153O(sek. Amid)1550-153O (sec. Amide)
Das erfindungsgemäße Verfahren wird anhand der folgenden Beispiele näher erläutert:The inventive method is based on the following examples are explained in more detail:
2-Oxo-1 -pyrrolidin-acetamid durch Cyclisieren
von 4-Chlorbutyrylglycinamid mit NaOH.2-Oxo-1-pyrrolidine-acetamide by cyclization
of 4-chlorobutyrylglycine amide with NaOH.
10 g (0,056 Mol) 4-Chlorbutyrylglycinamid werden unter Erwärmen bis zu 500C in 100 ml wasserfreiem Äthanol gelöst und der Lösung 5,9 ml 1 η Natriumhydroxid in Äthanol (0,056 Mol) unter Rühren tropfenweise zugefügt. Die Reaktionslösung wird 10 Minuten unter Rückflußkühlung bis zum Sieden erhitzt. Nach Abküh- ι ο lung wird das entstandene Natriumchlorid (2,9 g, 89%) durch Filtration abgetrennt Nach Entfernen des Lösungsmittels erhält man durch Zusatz von Isopropanol zum öligen Rückstand 63 g (86%) des weißen, kristallinen Produktes, Fp 145- 147°C.10 g (0.056 mol) of 4-chlorobutyrylglycine amide are dissolved in 100 ml of anhydrous ethanol with heating up to 50 ° C. and 5.9 ml of 1 η sodium hydroxide in ethanol (0.056 mol) are added dropwise with stirring. The reaction solution is refluxed for 10 minutes and heated to boiling. After cooling, the sodium chloride formed (2.9 g, 89%) is separated off by filtration. After removing the solvent, adding isopropanol to the oily residue gives 63 g (86%) of the white, crystalline product, mp 145 - 147 ° C.
2-Oxo-1 -pyrrolidin-acetamid durch Cyclisieren
mit Natrium-tert-Butylat.2-Oxo-1-pyrrolidine-acetamide by cyclization
with sodium tert-butoxide.
1515th
2020th
4 g (0,022 MoI) 4-Chlorbutyrylglycinamid werden in 80 ml Dioxan unter Erwärmen gelöst. Zur Lösung gibt man unter Rühren eine Suspension von 0,022 Mol Natrium-tert.-Butylat in 20 ml wasserfreiem Dioxan. Die Mischung wird bei Raumtemperatur eine Stunde gerührt, der Niederschlag (1,2 g, (94%)) durch Filtration abgetrennt. Die Mutterlauge wird bis zur Trockne eingedampft und das Rohprodukt aus Isopropanol kristallisiert, wodurch 2,24 g (72%) des Produktes erhalten werden, Fp 146-149° C.4 g (0.022 mol) of 4-chlorobutyrylglycine amide are dissolved in 80 ml of dioxane with heating. A suspension of 0.022 mol of sodium tert-butoxide in 20 ml of anhydrous dioxane is added to the solution with stirring. The mixture is stirred at room temperature for one hour, and the precipitate (1.2 g, (94%)) is separated off by filtration. The mother liquor is evaporated to dryness and the crude product crystallized from isopropanol to give 2.24 g (72%) of the product, M p 146-149 ° C.
Auf analoge Weise läßt sich die Ringschlußreaktion von 4-Chlorbutyrylglycinamid mit Natriummethylat oder -äthylat durchführen.The ring closure reaction of 4-chlorobutyrylglycine amide with sodium methylate can be carried out in an analogous manner or ethylate.
2-Oxo-1-pyrrolidin-acetamid durch Cyclisieren von 4-Chlor-butyrylglycinamid unter Anwendung eines Anionenaustausch^.2-Oxo-1-pyrrolidine-acetamide by cyclizing 4-chloro-butyrylglycine amide using a Anion exchange ^.
2,2 g (0,0124MoI) 4-Chlorbutyrylglycinamid werden in 15 ml wasserfreiem Äthanol gelöst und zu einer Suspension des Ionenaustauschers Dowex 1 in Äthanol gegeben. Die Suspension enthält 2OmI des trockenen Ionenaustauschers Dowex 1 in der OH-Form in 30 ml wasserfreiem ÄthanoL Das Reaktionsgemisch wird eine Stunde bei einer Temperatur von 2O-25°C gerührt. Anschließend wird der Austauscher abdekantiert und mit 20 ml Äthanol gewaschen. Das gesamte Äthanol wird dann abgedampft Aus dem festen Rückstand erhält man durch Umkristallisation aus Isopropanol 1,25 g (71 %) des Produktes, Fp 145 -147° C.2.2 g (0.0124MoI) of 4-chlorobutyrylglycine amide will be used dissolved in 15 ml of anhydrous ethanol and to one Added suspension of the ion exchanger Dowex 1 in ethanol. The suspension contains 20mI of the dry Ion exchanger Dowex 1 in the OH form in 30 ml of anhydrous EthanoL The reaction mixture is a Stirred at a temperature of 20-25 ° C. for an hour. The exchanger is then decanted and washed with 20 ml of ethanol. All of the ethanol is then evaporated from the solid residue 1.25 g (71%) of the product are obtained by recrystallization from isopropanol, melting point 145 ° -147 ° C.
Auf analoge Weise erhält man ein wesentlich reineres Rohprodukt nach Umkristallisation aus Isopropanol in Ausbeuten von 85% mit einem Fp von 148-1500C, wenn man mit einer mit dem Austauscher gefüllten Kolonne arbeitet.In an analogous way one obtains a much purer crude product after recrystallization from isopropanol in 85% yield with a F p of 148-150 0 C, when working with a column filled with the exchanger.
Claims (1)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
YU7776A YU39660B (en) | 1976-01-14 | 1976-01-14 | Process for obtaining 2-oxo-1-pyrrolidine acetamide |
YU198376A YU40148B (en) | 1976-08-11 | 1976-08-11 | Process for preparing n-subtituted amides of 2-oxo-pyrrolidines |
Publications (2)
Publication Number | Publication Date |
---|---|
DE2759297B1 true DE2759297B1 (en) | 1979-07-19 |
DE2759297C2 DE2759297C2 (en) | 1980-04-03 |
Family
ID=27130704
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE2701450A Expired DE2701450C2 (en) | 1976-01-14 | 1977-01-14 | Process for the preparation of N-substituted amides of 2-oxo-1-pyrrolidine |
DE2759297A Expired DE2759297C2 (en) | 1976-01-14 | 1977-01-14 | Process for the preparation of 2-oxo-1-pyrrolidine-acetamide |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE2701450A Expired DE2701450C2 (en) | 1976-01-14 | 1977-01-14 | Process for the preparation of N-substituted amides of 2-oxo-1-pyrrolidine |
Country Status (12)
Country | Link |
---|---|
JP (1) | JPS603320B2 (en) |
AT (1) | AT360980B (en) |
CH (1) | CH627742A5 (en) |
DD (1) | DD128591A5 (en) |
DE (2) | DE2701450C2 (en) |
FI (1) | FI66846C (en) |
FR (1) | FR2344535A1 (en) |
GB (2) | GB1549754A (en) |
HU (1) | HU173642B (en) |
NL (1) | NL7700408A (en) |
PL (1) | PL102996B1 (en) |
SE (1) | SE415972B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1539817A (en) * | 1976-10-22 | 1979-02-07 | Ucb Sa | N-substituted lactams |
EP0115473A3 (en) * | 1983-01-27 | 1987-01-21 | Ciba-Geigy Ag | Substituted pyrrolidinone derivatives and process for their preparation |
EP0115472A3 (en) * | 1983-01-27 | 1985-10-02 | Ciba-Geigy Ag | Pyrrolidinon derivatives and process for their preparation |
IT1190378B (en) * | 1985-06-21 | 1988-02-16 | Isf Spa | PYROLIDONIC DERIVATIVES |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3250784A (en) * | 1963-12-23 | 1966-05-10 | Gen Aniline & Film Corp | Pyrrolidonyl-gamma-butyramide and process of preparing |
GB1039113A (en) * | 1964-08-06 | 1966-08-17 | Ucb Sa | New n-substituted lactams |
GB1361388A (en) * | 1970-08-05 | 1974-07-24 | Geistlich Soehne Ag | Ny--sulphamoylaryl--pyrrolidines |
FR2363474A1 (en) * | 1976-09-03 | 1978-03-31 | Doris Dev Richesse Sous Marine | Sea bed anchor placing system - uses hydraulic motor driven borer at end of chain which carries pairs of pivoted flukes (NO 28.3.78) |
-
1977
- 1977-01-07 AT AT4377A patent/AT360980B/en not_active IP Right Cessation
- 1977-01-10 HU HU77PI558A patent/HU173642B/en unknown
- 1977-01-10 SE SE7700173A patent/SE415972B/en not_active IP Right Cessation
- 1977-01-11 GB GB1014/77A patent/GB1549754A/en not_active Expired
- 1977-01-11 GB GB38310/77A patent/GB1549755A/en not_active Expired
- 1977-01-12 FI FI770087A patent/FI66846C/en not_active IP Right Cessation
- 1977-01-12 DD DD7700196900A patent/DD128591A5/en unknown
- 1977-01-13 CH CH41577A patent/CH627742A5/en not_active IP Right Cessation
- 1977-01-14 DE DE2701450A patent/DE2701450C2/en not_active Expired
- 1977-01-14 JP JP52002549A patent/JPS603320B2/en not_active Expired
- 1977-01-14 DE DE2759297A patent/DE2759297C2/en not_active Expired
- 1977-01-14 PL PL1977195311A patent/PL102996B1/en not_active IP Right Cessation
- 1977-01-14 FR FR7701139A patent/FR2344535A1/en active Granted
- 1977-01-14 NL NL7700408A patent/NL7700408A/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE2759297C2 (en) | 1980-04-03 |
HU173642B (en) | 1979-07-28 |
CH627742A5 (en) | 1982-01-29 |
DE2701450C2 (en) | 1984-10-18 |
FR2344535A1 (en) | 1977-10-14 |
NL7700408A (en) | 1977-07-18 |
DE2701450A1 (en) | 1977-07-21 |
JPS52116462A (en) | 1977-09-29 |
AT360980B (en) | 1981-02-10 |
DD128591A5 (en) | 1977-11-30 |
FI770087A (en) | 1977-07-15 |
JPS603320B2 (en) | 1985-01-26 |
SE7700173L (en) | 1977-07-15 |
PL195311A1 (en) | 1978-02-27 |
SE415972B (en) | 1980-11-17 |
FR2344535B1 (en) | 1982-10-08 |
PL102996B1 (en) | 1979-05-31 |
FI66846C (en) | 1984-12-10 |
GB1549755A (en) | 1979-08-08 |
FI66846B (en) | 1984-08-31 |
GB1549754A (en) | 1979-08-08 |
ATA4377A (en) | 1979-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2560398C2 (en) | 2-Amino-thiazol-4-yl-acetic acid derivatives and processes for their preparation | |
AT376977B (en) | METHOD FOR PRODUCING NEW 5-SUBSTITUTED OXAZOLIDIN-2,4-DIONES AND THEIR SALTS | |
DE1620694B2 (en) | Process for the preparation of 5-methyl-7-diethylamino-s-triazolo [1,5-a] pyrimidine and its salts with acids | |
DE1593723A1 (en) | Process for the production of acetals | |
DE2851028C2 (en) | ||
DE2759297B1 (en) | Process for the preparation of 2-oxo-1-pyrrolidine-acetamide | |
CH412889A (en) | Process for the preparation of 2-methyl-3-oxypyridines | |
DE3872956T2 (en) | METHOD FOR PRODUCING 2,4-DIAMINO-6- (1-PIPERIDINYL) -PYRAMIDIN-N-OXIDE. | |
DE2420474B2 (en) | PROCESS FOR THE PRODUCTION OF BENZOINE ETHERS | |
DD142876A5 (en) | PROCESS FOR THE PREPARATION OF PYRROLIDINCARBOXALDEHYDE AND PIPERIDINCARBOXALDEHYDE DERIVATIVES | |
DE2661028C2 (en) | ||
DE2065698C3 (en) | Process for the preparation of 2-isopropyl-6-methyl-4 (3H) -pyrimidone | |
DE2122070A1 (en) | 1 Veratryl 4 methyl 5 ethyl 7,8 dimethoxy 2,3 diazabicyclo square brackets to 5,4,0 square brackets to undeca pentaen (1,3,6,8,10) and its use | |
DE3135840C1 (en) | 2-Azido-3-benzyloxy-propionic acid benzyl ester and process for its preparation | |
EP0159640A1 (en) | 4-Methoxy-2,2'-bipyridyl-6-aldoximes, process and intermediates for their preparation and their use as medicines | |
DD231073A1 (en) | PROCESS FOR PREPARING NEW AZABICYCLO (3.3.1) NONAN DERIVATIVES | |
CH650006A5 (en) | Process for the preparation of 5-fluorouracil derivatives | |
DE19647538A1 (en) | N-Substituted 2,2-di:phenyl-acetamide enantiomer preparation | |
AT214928B (en) | Process for the preparation of new camphidinium compounds | |
AT371448B (en) | METHOD FOR PRODUCING NEW CIS-4A-PHENYL-ISOCHINOLINE DERIVATIVES AND THEIR ACID ADDITION SALTS | |
AT356291B (en) | METHOD FOR THE PRODUCTION OF COMPOUNDS IN THE DIHYDROLYSERIC ACID AND DIHYDROISOLYER SERIES | |
AT372945B (en) | METHOD FOR PRODUCING NEW NSUBSTITUTED MORANOLINE DERIVATIVES | |
DE3382642T2 (en) | METHOD OF PRODUCING DERIVATIVES OF 3,5-DIOXOCYCLOHEXANCARBONIC ACID. | |
AT223197B (en) | Process for the preparation of new esters of N- (β-oxyethyl) -N '- [γ- (3'-chloro-10'-phenthiazinyl) -propyl] -piperazine | |
AT244344B (en) | Process for the preparation of new pyrimidine compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OI | Miscellaneous see part 1 | ||
OI | Miscellaneous see part 1 | ||
OD | Request for examination | ||
8328 | Change in the person/name/address of the agent |
Free format text: VON FUENER, A., DIPL.-CHEM. DR.RER.NAT. EBBINGHAUS, D., DIPL.-ING. FINCK, K., DIPL.-ING. DR.-ING., PAT.-ANW., 8000 MUENCHEN |
|
8339 | Ceased/non-payment of the annual fee |